Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, Snyder TA, Harvey CM, Teppler H, Dinubile MJ, Chow JW. Paterson DL, et al. J Antimicrob Chemother. 2005 Jun;55(6):965-73. doi: 10.1093/jac/dki117. Epub 2005 Apr 22. J Antimicrob Chemother. 2005. PMID: 15849262
Molecular analysis of the simultaneous production of two SHV-type extended-spectrum beta-lactamases in a clinical isolate of Enterobacter cloacae by using single-nucleotide polymorphism genotyping.
Szabó D, Melan MA, Hujer AM, Bonomo RA, Hujer KM, Bethel CR, Kristóf K, Paterson DL. Szabó D, et al. Among authors: paterson dl. Antimicrob Agents Chemother. 2005 Nov;49(11):4716-20. doi: 10.1128/AAC.49.11.4716-4720.2005. Antimicrob Agents Chemother. 2005. PMID: 16251316 Free PMC article.
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. Rossi F, et al. Among authors: paterson dl. J Antimicrob Chemother. 2006 Jul;58(1):205-10. doi: 10.1093/jac/dkl199. Epub 2006 May 22. J Antimicrob Chemother. 2006. PMID: 16717055
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Hawser SP, et al. Among authors: paterson dl. Antimicrob Agents Chemother. 2009 Aug;53(8):3280-4. doi: 10.1128/AAC.00426-09. Epub 2009 Jun 8. Antimicrob Agents Chemother. 2009. PMID: 19506060 Free PMC article.
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. Kumarasamy KK, et al. Among authors: paterson dl. Lancet Infect Dis. 2010 Sep;10(9):597-602. doi: 10.1016/S1473-3099(10)70143-2. Epub 2010 Aug 10. Lancet Infect Dis. 2010. PMID: 20705517 Free PMC article.
Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.
Waltner-Toews RI, Paterson DL, Qureshi ZA, Sidjabat HE, Adams-Haduch JM, Shutt KA, Jones M, Tian GB, Pasculle AW, Doi Y. Waltner-Toews RI, et al. Among authors: paterson dl. Antimicrob Agents Chemother. 2011 Feb;55(2):495-501. doi: 10.1128/AAC.00797-10. Epub 2010 Dec 6. Antimicrob Agents Chemother. 2011. PMID: 21135189 Free PMC article.
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Magiorakos AP, et al. Among authors: paterson dl. Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27. Clin Microbiol Infect. 2012. PMID: 21793988 Free article.
643 results